Yosemite closes on $200m for Fund II, targets $350m

New limited partner Amgen in the new healthcare fund joins returning LPs Emerson Collective, John Doerr, Massachusetts Institute of Technology and Memorial Sloan Kettering Cancer Center.

ByDavid Bogoslaw

2 February 2026•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Fundraising Managers North America US Emerging Managers Fundraising Healthcare Life Sciences Briefs

Yosemite closes on $200m for Fund II, targets $350m

Memorial Sloan-Kettering Cancer Center

Yosemite

Top North American PE firms

Venture Capital 50

Related articles